MK2461

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Advanced CancerNeoplasm

Phase 1

MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)

CompletedNCT00496353

Merck Sharp & Dohme LLCNeoplasm

Start: 2007-06-30End: 2008-11-30Updated: 2015-03-31

MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED)

CompletedNCT00518739

Merck Sharp & Dohme LLCAdvanced Cancer

Start: 2007-02-28End: 2008-12-31Updated: 2015-03-27